Table 3.

Prognosis of ICU-acquired bacteraemias in 48 patients whether they received or not an aminoglycoside as combination therapy

	Aminoglycoside not received		Aminoglycoside received		p-value
	n = 30		n = 18
	n	%	n	%
Bacteraemia complications	10	33	5	27	0.69
Septic shock	8	27	5	27	0.53
ARDS	1	3	0	0	1.00
Acute renal failure	3	9	2	11	1.00
Secondary nosocomial infection	16	54	8	44	0.55
Prognosis on day 28	Mean ± SD		Mean ± SD		p-value
Number of days alive free from mechanical ventilation	5.5 ±9.2		12.5 ± 9.3		0.02
	0 [0–10]		14 [0–21]
Number of days alive free from vasopressors	11.3 ± 12.4		19.3 ± 10.5		0.18
	3 [0–24]		24.5 [15–26]
Number of days alive free from RRT	5.4 ± 9.4		28		0.17
	0 [0–8.5]		28
Number of days alive away from ICU	3.2 ± 6.6		11.3 ± 8.9		0.002
	0 [0–2]		10 [0–20]
	n	%	n	%	p-value
ICU death	14	46	3	16	0.03
Patients discharged from ICU on day 28	8	26	13	72	0.002